Kits Eyecare releases Q1 2026 guidance

Executive Summary

• Kits Eyecare Ltd. projects Q1 2026 revenue of $58‑$60 million, reflecting 25%–29% organic growth and over 50% year‑over‑year growth in glasses revenue.
• Adjusted EBITDA margin is expected to be modestly higher, ranging from 4% to 6% of revenue.
• The company highlights a recently expanded $15 million credit facility, strong liquidity, and continued disciplined marketing investment to accelerate market‑share gains.

Key Details

• Revenue Guidance: $58 M – $60 M for the three months ended March 31, 2026 (25%–29% organic growth).
• Glasses Revenue: Expected to exceed $10 M, representing >50% YoY increase.
• Adjusted EBITDA Margin: Forecast at 4%‑6% of revenue.
• Strategic Investment: Ongoing marketing spend to boost brand awareness and capture additional market share.
• Financial Strength: Maintains significant liquidity; recently expanded a $15 M credit facility complementing an already robust balance sheet.
• Operational Highlights: Continued repeat‑customer growth, premium lens adoption, and operating leverage from its vertically integrated model.
• Management Commentary (CEO Roger Hardy): Emphasized disciplined execution, thoughtful investment, and the platform’s ability to compound value over time.

Notable Quotes

“Our performance continues to validate the strength of our vertically integrated model and our ability to capture share in a large, profitable category… As we continue to demonstrate sustained growth and earnings durability, we believe the quality of business is becoming increasingly evident.” – Roger Hardy, Co‑founder & CEO, Kits Eyecare Ltd.